Clinical Trials Logo

Healthy Volunteers clinical trials

View clinical trials related to Healthy Volunteers.

Filter by:

NCT ID: NCT05842798 Completed - Healthy Volunteers Clinical Trials

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TNM002 in Chinese Healthy Adults

Start date: October 15, 2021
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics properties of TNM002 following a single intramuscular dose in Chinese healthy adults.

NCT ID: NCT05836506 Completed - Healthy Volunteer Clinical Trials

A Study to Assess the Relative Bioavailability of Immediate Release Formulations of ABBV-903 in Healthy Adult Participants

Start date: April 18, 2023
Phase: Phase 1
Study type: Interventional

The main objective of this study is to assess the relative bioavailability and pharmacokinetics of ABBV-903 in healthy adult participants.

NCT ID: NCT05826574 Completed - Healthy Volunteers Clinical Trials

A Study to Assess Pharmacokinetics (PK) of Brensocatib Alone and With Multiple Doses of Rifampin or Esomeprozole in Healthy Participants

Start date: May 10, 2023
Phase: Phase 1
Study type: Interventional

The primary purpose of this study is to assess the effects of rifampin on the PK of brensocatib in Part 1 of the study and to assess the effects of esomeprazole on the PK of brensocatib in Part 2 of the study.

NCT ID: NCT05818956 Completed - Healthy Volunteers Clinical Trials

A Study of TAK-227 in Healthy Adults

Start date: May 25, 2023
Phase: Phase 1
Study type: Interventional

The main aim of this study is to test the effects of food consumption with sponsor compound TAK-227 in healthy participants. The study will also measure side effects, and to check how much TAK-227 stays in the blood over time to work out the best dose.

NCT ID: NCT05818514 Completed - Healthy Volunteers Clinical Trials

A PET Study to Determine Biodistribution and Binding Characteristics of [11C]AZ14132516 in Healthy Participants

Start date: April 27, 2023
Phase: Early Phase 1
Study type: Interventional

The purpose of this study is to measure the regional distribution and binding of [11C]AZ14132516 to CCR9 in the abdomen using PET-CT examination in healthy participants. Study details include: The study duration will be up to 60 days. The IV radioligand [11C]AZ14132516 will be administered at PET-CT examination: Visit 2 for the pilot panel; Visit 2 and 3 in the main panel. There will be 2 study visits for the pilot panel and 3 study visits for the main panel.

NCT ID: NCT05818306 Completed - Healthy Volunteers Clinical Trials

A Phase Ia Safety and Tolerability Study of BL-001

Start date: February 20, 2023
Phase: Phase 1
Study type: Interventional

To investigate the safety and tolerability of BL-001 in healthy volunteers for 28 consecutive days.

NCT ID: NCT05814926 Completed - Healthy Volunteers Clinical Trials

GP681 in Volunteers With Hepatic Impairment Compared With Healthy Volunteers

Start date: April 26, 2023
Phase: Phase 1
Study type: Interventional

The primary objective of this study is to test whether mild (Child-Pugh A, score 5-6) and moderate (Child-Pugh B, score 7-9) hepatic impairment affects pharmacokinetics, safety and tolerability of GP681, compared with a control group with normal hepatic function following oral administration of GP681 as single dose.

NCT ID: NCT05813717 Completed - Healthy Volunteers Clinical Trials

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986325 in Healthy Japanese Participants

Start date: April 10, 2023
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of BMS-986325 in healthy Japanese participants

NCT ID: NCT05806359 Completed - Healthy Volunteers Clinical Trials

A Study to Evaluate the Safety, Tolerability, and Drug Levels of Danicamtiv in Healthy Japanese and Caucasian Participants

Start date: March 31, 2023
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the safety, tolerability, and single-dose pharmacokinetics of danicamtiv in healthy Japanese and Caucasian participants.

NCT ID: NCT05805904 Completed - Healthy Volunteers Clinical Trials

A Study to Evaluate the Drug Levels, Safety, and Tolerability of BMS-986278 in Healthy Chinese Participants

Start date: March 29, 2023
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the drug levels, safety, and tolerability of BMS-986278 in healthy Chinese participants.